N2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma
Clinical trial NCT00295919 · COMPLETED
Trial details
- NCT number
- NCT00295919
- Sponsor
- New Approaches to Neuroblastoma Therapy Consortium
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-01
- Primary completion
- 2014-03-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.